Literature DB >> 15284295

Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein.

Guoqiang Zhang1, Xiaohe Cai, Jesús M López-Guisa, Sarah J Collins, Allison A Eddy.   

Abstract

The urokinase receptor (uPAR) attenuates myofibroblast recruitment and fibrosis in the kidney. This study examined the role of uPAR and its co-receptor LDL receptor-related protein (LRP) in the regulation of kidney fibroblast proliferation and extracellular signal-regulated kinase (ERK) signaling. Compared with uPAR+/+ cells, uPAR-/- kidney fibroblasts were hyperproliferative. UPAR-/- fibroblast proliferation was 60% inhibited by an ERK kinase inhibitor. LRP protein was reduced and extracellular accumulation of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) proteins were greater in uPAR-/- cultures. Addition of functional uPA protein or LRP antisense RNA significantly increased ERK signaling and cell mitosis in both genotypes. Enhanced uPAR-/- fibroblast proliferation was reversed by a recombinant nonfunctional uPA peptide. The density of cell-bound fluor-uPA was similar between uPAR-/- and uPAR+/+ fibroblasts (78 +/- 6 versus 92 +/- 16 units). These data suggest that uPAR-deficient kidney fibroblasts express lower levels of its scavenger co-receptor LRP, resulting in greater extracellular accumulation of uPA and PAI-1. Enhanced proliferation of uPAR-/- fibroblasts seems to be mediated by uPA-dependent ERK signaling via an alternative urokinase receptor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15284295     DOI: 10.1097/01.ASN.0000135057.41526.2C

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  8 in total

1.  Vitronectin accumulates in the interstitium but minimally impacts fibrogenesis in experimental chronic kidney disease.

Authors:  Jesús M López-Guisa; Allen C Rassa; Xiaohe Cai; Sarah J Collins; Allison A Eddy
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-26

2.  Maspin increases extracellular plasminogen activator activity associated with corneal fibroblasts and myofibroblasts.

Authors:  Debra J Warejcka; Malathi Narayan; Sally S Twining
Journal:  Exp Eye Res       Date:  2011-07-27       Impact factor: 3.467

3.  LRP-1--CD44, a new cell surface complex regulating tumor cell adhesion.

Authors:  Gwenn Perrot; Benoit Langlois; Jérôme Devy; Albin Jeanne; Laurie Verzeaux; Sébastien Almagro; Hervé Sartelet; Cathy Hachet; Christophe Schneider; Emilie Sick; Marion David; Michel Khrestchatisky; Hervé Emonard; Laurent Martiny; Stéphane Dedieu
Journal:  Mol Cell Biol       Date:  2012-06-18       Impact factor: 4.272

4.  LRP-1 promotes cancer cell invasion by supporting ERK and inhibiting JNK signaling pathways.

Authors:  Benoit Langlois; Gwenn Perrot; Christophe Schneider; Patrick Henriet; Hervé Emonard; Laurent Martiny; Stéphane Dedieu
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

Review 5.  Serine proteases, inhibitors and receptors in renal fibrosis.

Authors:  Allison A Eddy
Journal:  Thromb Haemost       Date:  2009-04       Impact factor: 5.249

6.  A novel signaling pathway: fibroblast nicotinic receptor alpha1 binds urokinase and promotes renal fibrosis.

Authors:  Guoqiang Zhang; Kelly A Kernan; Alison Thomas; Sarah Collins; Yumei Song; Ling Li; Weizhong Zhu; Renee C Leboeuf; Allison A Eddy
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

Review 7.  Urokinase and its receptors in chronic kidney disease.

Authors:  Guoqiang Zhang; Allison A Eddy
Journal:  Front Biosci       Date:  2008-05-01

8.  Mannose receptor 2 attenuates renal fibrosis.

Authors:  Jesús M López-Guisa; Xiaohe Cai; Sarah J Collins; Ikuyo Yamaguchi; Daryl M Okamura; Thomas H Bugge; Clare M Isacke; Claire L Emson; Scott M Turner; Stuart J Shankland; Allison A Eddy
Journal:  J Am Soc Nephrol       Date:  2011-11-17       Impact factor: 10.121

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.